Sports and Exercise in Athletes with Hypertrophic Cardiomyopathy.

[1]  J. O’Keefe,et al.  Dose of jogging and long-term mortality: the Copenhagen City Heart Study. , 2015, Journal of the American College of Cardiology.

[2]  F. Rutten,et al.  [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.

[3]  J. Saul,et al.  Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 Years of Age): a scientific statement from the American Heart Association and the American College of Cardiology. , 2014, Circulation.

[4]  B. Gersh,et al.  Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population , 2014, Journal of the American Heart Association.

[5]  C. Autore,et al.  Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors. , 2014, The American journal of cardiology.

[6]  A. Wilde,et al.  Which Patients Are Not Suitable for a Subcutaneous ICD: Incidence and Predictors of Failed QRS‐T‐Wave Morphology Screening , 2014, Journal of cardiovascular electrophysiology.

[7]  M. Ackerman,et al.  Pathogeneses of Sudden Cardiac Death in National Collegiate Athletic Association Athletes , 2014, Circulation. Arrhythmia and electrophysiology.

[8]  M. Silvis,et al.  The Dilemma of Genotype Positive-Phenotype Negative Hypertrophic Cardiomyopathy , 2014, Current sports medicine reports.

[9]  K. Harmon,et al.  Outcomes from sudden cardiac arrest in US high schools: a 2-year prospective study from the National Registry for AED Use in Sports , 2013, British Journal of Sports Medicine.

[10]  M. Link,et al.  Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry. , 2013, Circulation.

[11]  P. Elliott,et al.  Prevention of sudden cardiac death in hypertrophic cardiomyopathy , 2013, Heart.

[12]  E. Ashley,et al.  Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy. , 2013, The American journal of cardiology.

[13]  W. Manning,et al.  Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age , 2013, Circulation.

[14]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[15]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Journal of the American College of Cardiology.

[16]  C. Fahrenbruch,et al.  Incidence, Causes, and Survival Trends From Cardiovascular-Related Sudden Cardiac Arrest in Children and Young Adults 0 to 35 Years of Age: A 30-Year Review , 2012, Circulation.

[17]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[18]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[19]  Mathew G. Wilson,et al.  Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities? , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[20]  S. Abbara,et al.  Risk stratification for sudden cardiac death after septal myectomy. , 2011, Journal of cardiology cases.

[21]  Roger D. White,et al.  Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[22]  M. Burke,et al.  Use of a primary prevention totally subcutaneous defibrillator in hypertrophic cardiomyopathy. , 2010, Circulation. Arrhythmia and electrophysiology.

[23]  G. Bonsel,et al.  Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. , 2010, Europace.

[24]  M. Sheppard,et al.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[25]  P. Lambiase,et al.  Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. , 2009, European heart journal.

[26]  S. Day.  Exercise in Hypertrophic Cardiomyopathy , 2009, Journal of cardiovascular translational research.

[27]  J. Nielsen,et al.  Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[28]  W. Kraus,et al.  Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.

[29]  W. Kraus,et al.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.

[30]  T. Rowland.  Sudden Unexpected Death in Young Athletes: Reconsidering “Hypertrophic Cardiomyopathy” , 2009, Pediatrics.

[31]  B. Maron,et al.  Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2009, Circulation.

[32]  B. Maron,et al.  Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. , 2008, Journal of the American College of Cardiology.

[33]  B. Maron,et al.  Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy , 2008, Journal of cardiovascular electrophysiology.

[34]  B. Gersh,et al.  Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with latent obstruction. , 2008, American heart journal.

[35]  J. Myers,et al.  Exercise Capacity and Mortality in Black and White Men , 2008, Circulation.

[36]  B. Chaitman.  An Electrocardiogram Should Not Be Included in Routine Preparticipation Screening of Young Athletes , 2007, Circulation.

[37]  A. Keren,et al.  Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy , 2007, Heart.

[38]  C. Gaudio,et al.  Cumulative exercise-induced left ventricular systolic and diastolic dysfunction in hypertrophic cardiomyopathy. , 2007, International journal of cardiology.

[39]  M. Yamagishi,et al.  Exercise-induced systolic dysfunction in patients with non-obstructive hypertrophic cardiomyopathy and mutations in the cardiac troponin genes , 2007, Heart.

[40]  W. Mckenna,et al.  Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation , 2007, Heart.

[41]  H. Watkins,et al.  Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name? , 2007, Heart.

[42]  C. Long,et al.  Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. , 2007, American journal of physiology. Heart and circulatory physiology.

[43]  Fernando Costa,et al.  Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. , 2007, Circulation.

[44]  Barry J Maron,et al.  Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. , 2007, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[45]  S. Ommen,et al.  Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy. , 2007, The American journal of cardiology.

[46]  G. Kwakkel,et al.  Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: A meta‐analysis , 2006, European journal of heart failure.

[47]  Eloisa Arbustini,et al.  Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[48]  M. Link,et al.  Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2006, Circulation.

[49]  Barry J Maron,et al.  The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. , 2006, Circulation.

[50]  L. Leinwand,et al.  Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy , 2006, Circulation research.

[51]  D. Cannom,et al.  Safety of Sports Participation in Patients with Implantable Cardioverter Defibrillators: 
A Survey of Heart Rhythm Society Members , 2006, Journal of cardiovascular electrophysiology.

[52]  A. Tajik,et al.  Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[53]  M. Link,et al.  Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[54]  J. Towbin,et al.  Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. , 2005, Journal of the American College of Cardiology.

[55]  Lisa Pearse,et al.  Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits , 2004, Annals of Internal Medicine.

[56]  J. Towbin.  Molecular genetic basis of sudden cardiac death. , 2004, Pediatric clinics of North America.

[57]  Michael J Ackerman,et al.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. , 2004, Circulation.

[58]  C. Asher,et al.  Safety of stress testing in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.

[59]  M. Piepoli,et al.  Exercise training in patients with chronic heart failure , 2004, BMJ : British Medical Journal.

[60]  M. Piepoli,et al.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.

[61]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[62]  M. Link,et al.  Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. , 2003, Circulation.

[63]  Carlo Napolitano,et al.  Risk stratification in the long-QT syndrome. , 2003, The New England journal of medicine.

[64]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[65]  B. Maron,et al.  Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[66]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[67]  R. Myerburg,et al.  Scientific Gaps in the Prediction and Prevention of Sudden Cardiac Death , 2002, Journal of cardiovascular electrophysiology.

[68]  A. Tajik,et al.  Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. , 2002, Journal of the American College of Cardiology.

[69]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[70]  A. Motamedi,et al.  Quality of Life Assessment in Elite Collegiate Athletes * , 2001, The American journal of sports medicine.

[71]  M. Link,et al.  Report of the NASPE Policy Conference on Arrhythmias and the Athlete , 2001, Journal of cardiovascular electrophysiology.

[72]  B. Maron,et al.  Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy , 2001, Current cardiology reports.

[73]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[74]  J. Manson,et al.  Triggering of sudden death from cardiac causes by vigorous exertion. , 2000, The New England journal of medicine.

[75]  B. Maron,et al.  The paradox of exercise. , 2000, The New England journal of medicine.

[76]  B. Maron,et al.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. , 2000, Circulation.

[77]  G Thiene,et al.  Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. , 2000, Human pathology.

[78]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[79]  B. Maron,et al.  Competitive athletes with cardiovascular disease--the case of Nicholas Knapp. , 1998, The New England journal of medicine.

[80]  Barry I. Maron.  Cardiovascular Risks to Young Persons on the Athletic Field , 1998, Annals of Internal Medicine.

[81]  W. Mckenna,et al.  Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. , 1997, Circulation.

[82]  S. Oparil,et al.  Physical activity and cardiovascular health , 1996 .

[83]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[84]  R. Liberthson,et al.  Sudden death from cardiac causes in children and young adults. , 1996, The New England journal of medicine.

[85]  R. Cantu,et al.  Nontraumatic sports death in high school and college athletes. , 1995, Medicine and science in sports and exercise.

[86]  B. Maron,et al.  26th Bethesda Conferance: Recommendations for determining eligibility for competetion in athletes with cardiovascular abnormalities , 1994 .

[87]  B. Maron,et al.  Surviving competitive athletics with hypertrophic cardiomyopathy. , 1994, The American journal of cardiology.

[88]  I. Piña,et al.  Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association. , 1992, Circulation.

[89]  J. Seidman,et al.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.

[90]  M. Frenneaux,et al.  Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. , 1990, Circulation.

[91]  J. Mitchell,et al.  16th Bethesda Conference: Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. October 3-5, 1984. , 1985, Journal of the American College of Cardiology.

[92]  D. Siscovick,et al.  The incidence of primary cardiac arrest during vigorous exercise. , 1984, The New England journal of medicine.

[93]  R. Myerburg,et al.  Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload. , 1983, Journal of the American College of Cardiology.

[94]  P. Sorlie,et al.  Increased physical activity: a protective factor against heart attacks in Puerto Rico. , 1982, The American journal of cardiology.

[95]  M. Everitt,et al.  VIGOROUS EXERCISE IN LEISURE-TIME: PROTECTION AGAINST CORONARY HEART DISEASE , 1980, The Lancet.

[96]  W. Roberts,et al.  Sudden Death in Young Athletes , 1980, Circulation.

[97]  R. Paffenbarger,et al.  Work activity and coronary heart mortality. , 1975, The New England journal of medicine.

[98]  S. Chave,et al.  Vigorous exercise in leisure-time and the incidence of coronary heart-disease. , 1973, Lancet.

[99]  B. Maron.  Hypertrophic cardiomyopathy: an important global disease. , 2004, The American journal of medicine.

[100]  A. Tajik,et al.  Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy , 2002, Circulation.

[101]  G. Balady.  American College of Sports Medicine and American Heart Association Joint Position Statement : Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities , 1998 .

[102]  M. Mitten.  Team Physicians and Competitive Athletes: Allocating Legal Responsibility for Athletic Injuries , 1993 .